The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Interfacial inhibitors: targeting macromolecular complexes
Open accessAbstract
Interfacial inhibitors belong to a broad class of natural products and synthetic drugs that are commonly used to treat cancers as well as bacterial and HIV infections. They bind selectively to interfaces as macromolecular machines assemble and are set in motion. The bound drugs transiently arrest the targeted molecular machines, which can initiate allosteric effects, or desynchronize macromolecular machines that normally function in concert. Here, we review five archetypical examples of interfacial inhibitors: the camptothecins, etoposide, the quinolone antibiotics, the vinca alkaloids and the novel anti-HIV inhibitor raltegravir. We discuss the common and diverging elements between interfacial and allosteric inhibitors and give a perspective for the rationale and methods used to discover novel interfacial inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microtubules as a target for anticancer drugs
Jordan, M. A., & Wilson, L. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1317 · Cited by 4,000
Comparison of Experimental Binding Data and Theoretical Models in Proteins Containing Subunits*
Koshland, D. E., Némethy, G., & Filmer, D. (1966) · Biochemistry · doi:10.1021/bi00865a047 · Cited by 3,013
Topoisomerase I inhibitors: camptothecins and beyond
Pommier, Y. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1977 · Cited by 2,277
Self-citationAllosteric proteins and cellular control systems
Monod, J., Changeux, J.-P., & Jacob, F. (1963) · Journal of Molecular Biology · doi:10.1016/s0022-2836(63)80091-1 · Cited by 2,233
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
Wells, J. A., & McClendon, C. L. (2007) · Nature · doi:10.1038/nature06526 · Cited by 1,960
DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
Pommier, Y., Leo, E., Zhang, H., & Marchand, C. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.04.012 · Cited by 1,829
Self-citationMicrotubule-binding agents: a dynamic field of cancer therapeutics
Dumontet, C., & Jordan, M. A. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3253 · Cited by 1,718
Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain
Ravelli, R. B. G., Gigant, B., Curmi, P. A., Jourdain, I., Lachkar, S., Sobel, A., & Knossow, M. (2004) · Nature · doi:10.1038/nature02393 · Cited by 1,630
Structure of the FKBP12-Rapamycin Complex Interacting with Binding Domain of Human FRAP
Choi, J., Chen, J., Schreiber, S. L., & Clardy, J. (1996) · Science · doi:10.1126/science.273.5272.239 · Cited by 929
Tewey, K. M., Chen, G. L., Nelson, E. M., & Liu, L. F. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)47282-6 · Cited by 887
Type IIA topoisomerase inhibition by a new class of antibacterial agents
Bax, B. D., Chan, P. F., Eggleston, D. S., Fosberry, A., Gentry, D. R., Gorrec, F., Giordano, I., Hann, M. M., Hennessy, A., Hibbs, M., et al. (2010) · Nature · doi:10.1038/nature09197 · Cited by 860
X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex
Griffith, J. P., Kim, J. L., Kim, E. E., Sintchak, M. D., Thomson, J. A., Fitzgibbon, M. J., Fleming, M. A., Caron, P. R., Hsiao, K., & Navia, M. A. (1995) · Cell · doi:10.1016/0092-8674(95)90439-5 · Cited by 834
Nalidixic acid resistance: A second genetic character involved in DNA gyrase activity
Gellert, M., Mizuuchi, K., O'Dea, M. H., Itoh, T., & Tomizawa, J.-I. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.11.4772 · Cited by 833
The mechanism of topoisomerase I poisoning by a camptothecin analog
Staker, B. L., Hjerrild, K., Feese, M. D., Behnke, C. A., Burgin, A. B., & Stewart, L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242259599 · Cited by 818
Crystal Structure of the Catalytic Domains of Adenylyl Cyclase in a Complex with G sα ·GTPγS
Tesmer, J. J. G., Sunahara, R. K., Gilman, A. G., & Sprang, S. R. (1997) · Science · doi:10.1126/science.278.5345.1907 · Cited by 796
Sugino, A., Peebles, C. L., Kreuzer, K. N., & Cozzarelli, N. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.11.4767 · Cited by 784
Crystal structures of human calcineurin and the human FKBP12–FK506–calcineurin complex
Kissinger, C. R., Parge, H. E., Knighton, D. R., Lewis, C. T., Pelletier, L. A., Tempczyk, A., Kalish, V. J., Tucker, K. D., Showalter, R. E., Moomaw, E. W., et al. (1995) · Nature · doi:10.1038/378641a0 · Cited by 762
Direct inhibition of the NOTCH transcription factor complex
Moellering, R. E., Cornejo, M., Davis, T. N., Bianco, C. D., Aster, J. C., Blacklow, S. C., Kung, A. L., Gilliland, D. G., Verdine, G. L., & Bradner, J. E. (2009) · Nature · doi:10.1038/nature08543 · Cited by 752
Structural basis for the regulation of tubulin by vinblastine
Gigant, B., Wang, C., Ravelli, R. B. G., Roussi, F., Steinmetz, M. O., Curmi, P. A., Sobel, A., & Knossow, M. (2005) · Nature · doi:10.1038/nature03566 · Cited by 734
Integrase inhibitors to treat HIV/Aids
Pommier, Y., Johnson, A. A., & Marchand, C. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1660 · Cited by 688
Self-citationRetroviral intasome assembly and inhibition of DNA strand transfer
Hare, S., Gupta, S. S., Valkov, E., Engelman, A., & Cherepanov, P. (2010) · Nature · doi:10.1038/nature08784 · Cited by 678 · cited 1×
“Stunning co-crystal structures of integrase with its viral substrates have revealed the trapping of the integrase–DNA complex as the drugs bind at its interfac”
Staker, B. L., Feese, M. D., Cushman, M., Pommier, Y., Zembower, D., Stewart, L., & Burgin, A. B. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049146p · Cited by 546
Self-citationStructural Basis of Type II Topoisomerase Inhibition by the Anticancer Drug Etoposide
Wu, C.-C., Li, T.-K., Farh, L., Lin, L.-Y., Lin, T.-S., Yu, Y.-J., Yen, T.-J., Chiang, C.-W., & Chan, N.-L. (2011) · Science · doi:10.1126/science.1204117 · Cited by 523
DNA topoisomerase-targeting antitumor drugs can be studied in yeast.
Nitiss, J., & Wang, J. C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.20.7501 · Cited by 499
Chen, G. L., Yang, L., Rowe, T. C., Halligan, B. D., Tewey, K. M., & Liu, L. F. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)90729-5 · Cited by 492
Jaxel, C., Kohn, K. W., Wani, M. C., Wall, M. E., & Pommier, Y. G. (1989) · PubMed · Cited by 449
Self-citationThe Binding Mode of Epothilone A on α,ß-Tubulin by Electron Crystallography
Nettles, J. H., Li, H., Cornett, B., Krahn, J. M., Snyder, J. P., & Downing, K. H. (2004) · Science · doi:10.1126/science.1099190 · Cited by 421
X-ray structures of general anaesthetics bound to a pentameric ligand-gated ion channel
Nury, H., Van Renterghem, C., Weng, Y., Tran, A., Baaden, M., Dufresne, V., Changeux, J.-P., Sonner, J. M., Delarue, M., & Corringer, P.-J. (2011) · Nature · doi:10.1038/nature09647 · Cited by 412
Burgin, A. B., Magnusson, O. T., Singh, J., Witte, P., Staker, B. L., Bjornsson, J. M., Thorsteinsdottir, M., Hrafnsdottir, S., Hagen, T., Kiselyov, A. S., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1598 · Cited by 397
The binding conformation of Taxol in β-tubulin: A model based on electron crystallographic density
Snyder, J. P., Nettles, J. H., Cornett, B., Downing, K. H., & Nogales, E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051309398 · Cited by 362
Takebayashi, Y., Pourquier, P., Zimonjic, D. B., Nakayama, K., Emmert, S., Ueda, T., Urasaki, Y., Kanzaki, A., Akiyama, S.-I., Popescu, N., et al. (2001) · Nature Medicine · doi:10.1038/91008 · Cited by 348
Self-citationStructural view of a fungal toxin acting on a 14-3-3 regulatory complex
Würtele, M., Jelich-Ottmann, C., Wittinghofer, A., & Oecking, C. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg104 · Cited by 348
Roca, J., Ishida, R., Berger, J. M., Andoh, T., & Wang, J. C. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.5.1781 · Cited by 348
Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin.
Eng, W. K., Faucette, L., Johnson, R. K., & Sternglanz, R. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10121-1 · Cited by 325
Structural snapshots of the mechanism and inhibition of a guanine nucleotide exchange factor
Renault, L., Guibert, B., & Cherfils, J. (2003) · Nature · doi:10.1038/nature02197 · Cited by 320
Structural basis of transcription: α-Amanitin–RNA polymerase II cocrystal at 2.8 Å resolution
Bushnell, D. A., Cramer, P., & Kornberg, R. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251664698 · Cited by 315
Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance
Hare, S., Vos, A. M., Clayton, R. F., Thuring, J. W., Cummings, M. D., & Cherepanov, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010246107 · Cited by 305
Structural insight into the quinolone–DNA cleavage complex of type IIA topoisomerases
Laponogov, I., Sohi, M. K., Veselkov, D. A., Pan, X.-S., Sawhney, R., Thompson, A. W., McAuley, K. E., Fisher, L. M., & Sanderson, M. R. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1604 · Cited by 304
Pommier, Y., Kohlhagen, G., Bailly, C., Waring, M., Mazumder, A., & Kohn, K. W. (1996) · Biochemistry · doi:10.1021/bi960306b · Cited by 303
Self-citationAntitumour drugs impede DNA uncoiling by topoisomerase I
Koster, D. A., Palle, K., Bot, E. S. M., Bjornsti, M.-A., & Dekker, N. H. (2007) · Nature · doi:10.1038/nature05938 · Cited by 299
The mechanism of retroviral integration from X-ray structures of its key intermediates
Maertens, G. N., Hare, S., & Cherepanov, P. (2010) · Nature · doi:10.1038/nature09517 · Cited by 296
Repair of Topoisomerase I‐Mediated DNA Damage
Pommier, Y., Barcelo, J. M., Rao, V. A., Sordet, O., Jobson, A. G., Thibaut, L., Miao, Z., Seiler, J. A., Zhang, H., Marchand, C., et al. (2006) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(06)81005-6 · Cited by 291
Self-citationHuai, Q., Kim, H.-Y., Liu, Y., Zhao, Y., Mondragon, A., Liu, J. O., & Ke, H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192206699 · Cited by 277
Hare, S., Smith, S. J., Métifiot, M., Jaxa-Chamiec, A., Pommier, Y., Hughes, S. H., & Cherepanov, P. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.073189 · Cited by 264
Self-citationClassen, S., Olland, S., & Berger, J. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1832879100 · Cited by 263
Brueckner, F., & Cramer, P. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1458 · Cited by 259
Crystal structure of human calcineurin complexed with cyclosporin A and human cyclophilin
Jin, L., & Harrison, S. C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212504399 · Cited by 244
Mossessova, E., Corpina, R. A., & Goldberg, J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00475-1 · Cited by 242
Conti, C., Saccà, B., Herrick, J., Lalou, C., Pommier, Y., & Bensimon, A. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-08-0689 · Cited by 236
Self-citationCatalytic inhibitors of DNA topoisomerase II
Andoh, T., & Ishida, R. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00133-x · Cited by 231
Structure-based modeling of the functional HIV-1 intasome and its inhibition
Krishnan, L., Li, X., Naraharisetty, H. L., Hare, S., Cherepanov, P., & Engelman, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002346107 · Cited by 191
Capranico, G., Kohn, K. W., & Pommier, Y. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.22.6611 · Cited by 186
Self-citationTopoisomerase I inhibitors: selectivity and cellular resistance
Pommier, Y., Pourquier, P., Urasaki, Y., Wu, J., & Laco, G. S. (1999) · Drug Resistance Updates · doi:10.1054/drup.1999.0102 · Cited by 182
Self-citationStructural Basis of Gate-DNA Breakage and Resealing by Type II Topoisomerases
Laponogov, I., Pan, X.-S., Veselkov, D. A., McAuley, K. E., Fisher, L. M., & Sanderson, M. R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011338 · Cited by 178
Marchand, C., Antony, S., Kohn, K. W., Cushman, M., Ioanoviciu, A., Staker, B. L., Burgin, A. B., Stewart, L., & Pommier, Y. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0456 · Cited by 167
Self-citationInterfacial inhibition of macromolecular interactions: nature's paradigm for drug discovery
Pommier, Y., & Cherfils, J. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.01.008 · Cited by 165
Self-citationHibbs, R. E., Sulzenbacher, G., Shi, J., Talley, T. T., Conrod, S., Kem, W. R., Taylor, P., Marchot, P., & Bourne, Y. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.227 · Cited by 164
Capranico, G., Zunino, F., Kohn, K. W., & Pommier, Y. G. (1990) · Biochemistry · doi:10.1021/bi00454a033 · Cited by 156
Self-citationIshida, R., Sato, M., Narita, T., Utsumi, K. R., Nishimoto, T., Morita, T., Nagata, H., & Andoh, T. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.126.6.1341 · Cited by 156
Fujimori, A., Harker, W. G., Kohlhagen, G., Hoki, Y., & Pommier, Y. G. (1995) · PubMed · Cited by 151
Self-citationRejuvenation of CcdB-Poisoned Gyrase by an Intrinsically Disordered Protein Domain
Jonge, N. D., Garcia‐Pino, A., Buts, L., Haesaerts, S., Charlier, D., Zangger, K., Wyns, L., Greve, H. D., & Loris, R. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.05.025 · Cited by 151
Molecular Basis of Gyrase Poisoning by the Addiction Toxin CcdB
Dao‐Thi, M., Melderen, L. V., Genst, E. D., Afif, H., Buts, L., Wyns, L., & Loris, R. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.03.049 · Cited by 146
Laurberg, M., Kristensen, O., Martemyanov, K. A., Gudkov, A. T., Нагаев, И. Ю., Hughes, D., & Liljas, A. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4168 · Cited by 141
Mechanisms of Camptothecin Resistance by Human Topoisomerase I Mutations
Chrencik, J., Staker, B. L., Burgin, A. B., Pourquier, P., Pommier, Y. G., Stewart, L. J., & Redinbo, M. R. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.03.077 · Cited by 136
Self-citationStructural biology of retroviral DNA integration
Li, X., Krishnan, L., Cherepanov, P., & Engelman, A. (2011) · Virology · doi:10.1016/j.virol.2010.12.008 · Cited by 118
Nicotinic receptors, allosteric proteins and medicine
Changeux, J., & Taly, A. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.01.001 · Cited by 115
Ioanoviciu, A., Antony, S., Pommier, Y. G., Staker, B. L., Stewart, L. J., & Cushman, M. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050076b · Cited by 111
Self-citationSirikantaramas, S., Yamazaki, M., & Saito, K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801038105 · Cited by 111
A Closer Look at the High Affinity Benzodiazepine Binding Site on GABAA Receptors
Sigel, E., & Lüscher, B. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611794863562 · Cited by 106
Resistance to Integrase Inhibitors
Métifiot, M., Marchand, C., Maddali, K., & Pommier, Y. G. (2010) · Viruses · doi:10.3390/v2071347 · Cited by 106
Self-citationHIV-1 IN Inhibitors: 2010 Update and Perspectives
Marchand, C., Maddali, K., Métifiot, M., & Pommier, Y. G. (2009) · Current Topics in Medicinal Chemistry · doi:10.2174/156802609789630910 · Cited by 92
Self-citation50th anniversary of the word “allosteric”
Changeux, J. (2011) · Protein Science · doi:10.1002/pro.658 · Cited by 90
A Crystal Structure of the Bifunctional Antibiotic Simocyclinone D8, Bound to DNA Gyrase
Edwards, M. J., Flatman, R. H., Mitchenall, L. A., Stevenson, C. E. M., Le, T. B. K., Clarke, T. A., McKay, A. R., Fiedler, H., Buttner, M. J., Lawson, D. M., et al. (2009) · Science · doi:10.1126/science.1179123 · Cited by 90
The Interaction of Drugs with DNA Gyrase: A Model for the Molecular Basis of Quinolone Action
Heddle, J. G., Barnard, F. M., Wentzell, L. M., & Maxwell, A. (2000) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770008033048 · Cited by 83
Elvitegravir overcomes resistance to raltegravir induced by integrase mutation Y143
Métifiot, M., Vandegraaff, N., Maddali, K., Naumova, A., Zhang, X., Rhodes, D., Marchand, C., & Pommier, Y. G. (2011) · AIDS · doi:10.1097/qad.0b013e3283473599 · Cited by 80
Self-citationInterfacial Inhibitors of Protein-Nucleic Acid Interactions
Pommier, Y. G., & Marchand, C. (2005) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1568011054222337 · Cited by 74
Self-citationCapranico, G., Isabella, P. D., Tinelli, S., Bigioni, M., & Zunino, F. (1993) · Biochemistry · doi:10.1021/bi00063a015 · Cited by 59
Structural studies of the translational apparatus
Agrawal, R. K., & Frank, J. (1999) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(99)80031-1 · Cited by 53
Interaction of Thiostrepton and Elongation Factor-G with the Ribosomal Protein L11-binding Domain
Bowen, W. S., Dyke, N. V., Murgola, E. J., Lodmell, J. S., & Hill, W. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407008200 · Cited by 43
Development of tricyclic hydroxy-1H-pyrrolopyridine-trione containing HIV-1 integrase inhibitors
Zhao, X. Z., Maddali, K., Métifiot, M., Smith, S. J., Vu, B. C., Marchand, C., Hughes, S. H., Pommier, Y. G., & Burke, T. R. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.03.047 · Cited by 23
Self-citationIntroduction and Historical Perspective
Forterre, P. (2011) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-4614-0323-4_1 · Cited by 12
Cited by
Structural basis of PROTAC cooperative recognition for selective protein degradation
Gadd, M. S., Testa, A., Lucas, X., Chan, K.-H., Chen, W., Lamont, D. J., Zengerle, M., & Ciulli, A. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2329 · Cited by 1,242
Roles of eukaryotic topoisomerases in transcription, replication and genomic stability
Pommier, Y., Sun, Y., Huang, S.-Y. N., & Nitiss, J. L. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.111 · Cited by 950
Self-citationDrugging Topoisomerases: Lessons and Challenges
Pommier, Y. (2013) · ACS Chemical Biology · doi:10.1021/cb300648v · Cited by 839
Self-citationOn the binding affinity of macromolecular interactions: daring to ask why proteins interact
Kastritis, P. L., & Bonvin, A. M. J. J. (2013) · Journal of The Royal Society Interface · doi:10.1098/rsif.2012.0835 · Cited by 520
Modulators of Protein–Protein Interactions
Milroy, L.-G., Grossmann, T. N., Hennig, S., Brunsveld, L., & Ottmann, C. (2014) · Chemical Reviews · doi:10.1021/cr400698c · Cited by 497
Metadata
- Authors
- Pommier, Y., & Marchand, C.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2011-12-16
- Volume
- 11
- Issue
- 1
- Pages
- 25-36
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2005601312
- Cited by
- 259
- References
- 81
- FWCI
- 1.35
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.